For example, a positive thyroid autoantibody titer was highly correlated with increased survival in patients with renal cell carcinoma who received interleukin-2 (IL-2) and interferon-alfa 2 therapy [28]. This evidence concerns the gene IL2 and hereditary clear cell renal cell carcinoma.